FDA Official: Puberty Blockers Have Mental Health Risks

An FDA official recommended approving puberty blockers for youth with gender dysphoria while acknowledging that a study showed the drugs were associated with an “increased risk in depression and suicidality,” according to internal emails released by America First Legal.[#item_full_content]